Clinical Trials Browser

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

Advanced Solid Tumour

Locally Advanced or Metastatic Solid Tumours

Mesothelioma, Malignant, Mesothelioma

Adult Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumors

Mesothelioma, Malignant

Mesothelioma

Solid Tumors

Advanced Solid Tumor

Unspecified Adult Solid Tumor, Protocol Specific

Mesothelioma, Malignant, Mesothelioma

Advanced Solid Tumours

Advanced Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumor

Solid Tumors

Advanced Solid Tumor

Mesothelioma, Malignant, Mesothelioma

Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Metastatic Solid Tumors

Advanced Solid Tumors

Solid Tumors

Mesothelioma, Malignant

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumor

Mesothelioma

Solid Tumors

Solid Tumors

Solid Tumors

Solid Tumors

Mesothelioma, Malignant, Mesothelioma

Cholangiocarcinoma of the Gallbladder

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Unspecified Adult Solid Tumor, Protocol Specific

Mesothelioma, Malignant

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

TRESR

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

INFINITE

RAMES

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

MK-1775-001

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

M6620 First in Human Study

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

LBH589 and Gemcitabine in the Treatment of Solid Tumors

Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer